Best Biopharma Outsourcing Companies in Texas, United States
The 116 best Biopharma Outsourcing companies in Texas, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Elligo.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Texas
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3rd Coast Research Associates Clinical research site, specialized in phase II-IV trials | — | — | — | 2013 | Sonia Plemons Co-Founder | — | — | — |
| 2 | Align CRO Clinical research service provider for early phase cancer clinical trials | — | — | — | 2006 | Merrick Reese CEO | — | — | — |
| 3 | Altogen Labs Preclinical CRO providing xenograft models, toxicology, and RNAi services | — | — | 2 | 2008 | — | WordPress Block EditorWordPressMySQL+12 | — | — |
| 4 | Apex Mobile Clinical Research CRO focused on clinical trial solutions | — | — | 10 | 2021 | — | — | — | — |
| 5 | Aspen Insights Manufacturer of clinical trial and research services | — | — | 12 | 2019 | — | — | — | — |
| 6 | Austin Clinical Research Clinical research company conducting clinical trials for the pharmaceutical industry | — | — | — | 1996 | Dana Austin Founder | — | — | — |
| 7 | Avance Biosciences Company offering sequencing and PCR based services for assay validation and other clinical trial applications | — | — | 77 77 → 55 (-29%) | 2010 | Qin Xiang Sr. Director/Co Founder | — | — | — |
| 8 | Benchmark Research Advancing clinical research to improve patient lives through meaningful connections | — | — | 83 | 1997 | — | WordPress Block EditorwpBakeryWordPress+27 | — | — |
Top 12 Biopharma Outsourcing companies in Texas
#1
Public · San Antonio, Texas · founded 2021 · 60 employees$14.4Mraised▾
Provider of CRO & CDMO services for biologics
- Jan 2025Post IPO$1M
- Dec 2024Post IPO$13.4M
#2
Series B · San Antonio, Texas · founded 2007$16.9Mraised▾
Provider of early-phase oncology clinical trials and research services. It focuses on accelerating anticancer drug development to improve cancer patients' quality of life and survival. It offers preclinical and early-phase clinical trial services, connecting patients, physicians, and advocacy groups to community-based cancer trials. The company conducts research across solid tumors and hematologic malignancies, working with biopharma sponsors, CROs, and physicians. It provides a centralized network of research facilities with integrated processes to support protocol design, patient databases, and regulatory document management.
- Jul 2024Series B$16.9M
#3
Series E · Austin, Texas · founded 2016 · 280 employees$176.5Mraised▾
CRO focused on providing patient recruitment, site activation, study initiation and closeout services
- Oct 2023Venture Debt$40M
- Sep 2021Series E$135M
- Dec 2020Series C—
- May 2019Series C$20M
#4
Funding Raised · Austin, Texas · founded 1999 · 121 employees$793.1Kraised▾
Provider of data management services
- Apr 2025Grant (prize money)$645.1K
- Jan 2017Grant (prize money)—
- Sep 2011Grant (prize money)$148K
#5
Seed · Texas · founded 2019 · 8 employees$13Mraised▾
Manufacturer of industrial and therapeutic proteins
- Nov 2023Seed$9M
- Sep 2023Seed$4M
#6
Series C · Georgetown, Texas · founded 2007 · 58 employees$58Mraised▾
Provider of preclinical & formulation development, analytical, and market strategy services
- Oct 2020Series C$4.7M
- Apr 2018Series C$27M
- Jan 2016Series B$12M
- Feb 2015Series B$10M
#7
Funding Raised · Georgetown, Texas · founded 2007 · 54 employees$57.4Mraised▾
DisperSol Technologies evolved from a research collaboration with the College of Pharmacy at The University of Texas at Austin. It provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules. The company's proprietary KinetiSol technology is based on a commercial plastic compounding process that is cGMP compliant. The company claims that it has advantages over spray drying and hot melt extrusion for highly insoluble drugs. DisperSol offers a variety of services including formulation/process research and development for fusion and solvent-based processes, solid-state and chemical characterization, accelerated stability testing, in-vitro/in-vivo performance analysis, drug product manufacturing for pre-clinical and early-phase clinical studies, as well as formulation and process development consulting.
#8
Acquired · Austin, Texas · founded 2013 · 23 employees$14.9Mraised▾
Clinical trial recruitment service company. The platform collects data from the provider’s EHR and uses it to match the provider’s patients with clinical trials and preventative procedures that recently received FDA clearance. Clients are the life sciences companies who want to accelerate recruiting for their clinical trials and provide a new way to market their new products.
- Sep 2017Series B$2.6M
- Jun 2016Series B$8.3M
- Feb 2015Series A$2.6M
- May 2014Seed$1.4M
#9
Seed · Houston, Texas · founded 2021 · 23 employees$615.5Kraised▾
Operator of a biotechnology research company intended to support clients to create therapies for patients. The company provides experienced research managers and staff, with a mouse vivarium, through a mix of shared and private research laboratory spaces, enabling clients to get access to research facilities at an affordable cost.
- Aug 2023Seed$615.5K
#10
Acquired · Cypress, Texas · founded 1998 · 229 employees$17Mraised▾
Paid clinical trials in Los Angeles and Orange County, California. This clinical research organization conducts clinical trials to explore new methods for disease prevention, detection, and treatment. By participating in clinical trials, volunteers contribute to medical advancements and improve lives. The organization prioritizes participant safety and well-being while advancing research and life-saving therapeutics. They offer various trials, including outpatient visits and inpatient studies, to suit different needs. The organization provides services to the biotechnology, pharmaceutical, and medical device industries, helping develop specialized medicines and therapies. Stay informed with their blog for the latest clinical trial news and insights. They are committed to advancing medical science through rigorous clinical research.
- Jun 2015PE$17M
- Jan 2012PE—
#11
Deadpooled · Austin, Texas · founded 2014$3.5Mraised▾
Provider of clinical development services focused on immuno-oncology diseases
- Jun 2017Seed$1.1M
- Sep 2015Seed$2.4M
#12
Funding Raised · Houston, Texas · founded 2020 · 4 employees$1.4Mraised▾
Developer of precision medicine platforms using functional genomics and machine learning. These platforms aid in rare disease diagnosis, drug target discovery, and clinical trial patient stratification. The company integrates massively multiplexed experiments with human biobank data to classify variants of uncertain significance (VUS), predict drug responses, and prioritize high-confidence drug targets. A key offering provides functional evidence for the clinical genetics community, improving the efficiency of VUS resolution. The technology accelerates drug development and improves patient access to treatments.
- Mar 2020Grant (prize money)$1.3M
- Jan 2020Grant (prize money)$150K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Texas is moving
A read on the academic research around Biotechnology in Texas — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 297 papers.
Texas A&M and UT Southwestern lead moderately optimistic research (mean 0.53) dominated by CRISPR, bacterial genetics, and DNA repair, with breakthroughs and advancements far outpacing concerns.
- Texas A&M University75
- The University of Texas Southwestern Medical Center41
- The University of Texas MD Anderson Cancer Center39
- Texas Tech University38
- The University of Texas at Austin31
- Gene1→11
- Gene expression1→4
- Mutation1→4
- Cell1→3
- Messenger RNA2→3
- Selection (genetic algorithm)1→3
- Phenotype1→3
- Disease3
- Abiotic stress2
- T cell2
- Sustainability2
- Livestock2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.